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Glucose1. Introduction
Enzyme-based electrochemical biosensors are used for a multitude
of applications; they employ a wide variety of oxidoreductases, and
are found in many analytical instruments used in environmental, food,
pharmaceutical and clinical laboratories [1]. The stand-out, most suc-
cessful application is electrochemical biosensors for glucose sensing;
these now help millions of diabetic people manage their condition,
and many new biosensor designs are reported yearly in the literature
[2,3]. Some type 1 diabetics find it difficult to manage hypoglycaemic
events, which can lead to the need for emergency medical intervention.
One means to reduce the need for such intervention is to employ Con-
tinuous Glucose Monitoring (CGM) devices which are implanted
under the skin, where they reside for typically a week. CGM has proven
very useful for understanding and managing individual patient thera-
peutic regimes. However, a number of challenges are faced in this
field including poor device accuracy, narrow linear range and the
short lifetime of implanted devices [4]. Apart from invasive sensors,
wearable electrochemical sensors have received considerable recent in-
terest and could potentially be employed for CGM, operating in tears,
sweat or saliva [5].
Many glucose biosensors use additional electroactive mediators to
operate. Due to the possible toxicity of themediators [6], their use in im-
plantable devices is however problematic, e.g. in CGM devices. Anotheranoband array electrode as
g/10.1016/j.bioelechem.2016.commonway to produce a glucose sensor, also employed in the major-
ity of the CGM devices currently on the market [4], is to use a so-called
first generation glucose biosensor design,where GOx turns over glucose
in the presence of its natural co-substrate oxygen, producing hydrogen
peroxide [2]. Hydrogen peroxide is then electrochemically oxidised at a
Pt electrode by applying an anodic potential:
glucoseþ O2
GOx
→ gluconic acidþH2O2 ð1Þ
H2O2→O2 þ 2Hþ þ 2e: ð2Þ
Onedrawbackwith such a biosensor design is that the concentration
of dissolved oxygen is typically much lower than that of the glucose,
meaning that the response of the device is determined by the availabil-
ity of oxygen [3].Oxygen and glucose concentrations need to be con-
trolled with diffusion membranes, which necessarily also reduces the
glucose concentration at the electrode surface and generates mass
transfer limitations [7,8].
By employing different nanomaterials in the design of biosensors,
considerable improvements in sensitivity, selectivity, and accuracy can
been achieved [9,10]. Different nanomaterials such as nanoparticles,
nanofibres, nanotubes and nanocomposites have been used to modify
macro-scale electrodes. Many different strategies have been developed
to immobilise enzymes on these nanostructured macro-electrodes,
whichhave resulted in enhanced redox currents. This has been achieved
by stabilising surface interactions with the adsorbed enzymes anda platform for high sensitivity enzyme-based glucose biosensing,
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2 M. Falk et al. / Bioelectrochemistry xxx (2016) xxx–xxxpresenting a high surface-to-volume ratio to enable a high enzyme load
[11].
Instead of employing nanomaterials-modified macro-scale elec-
trodes in the biosensor design, another approach is to use
nanoelectrodes or nanoelectrode arrays [6,12,13]. The electrochemical
properties of nanoelectrodes differ significantly from those of macro-
scale electrodes, and are characterised by enhanced and often steady-
state (time independent) diffusion. This enhanced mass transport pro-
vides several benefits, including increased signal-to-noise ratio and
high sensitivity. This has already been shown to provide high sensitivity
for biorecognition reactions [13,14]. Thus, an important potential appli-
cation of nanoelectrodes is in bioanalytical measurement systems, e.g.
for healthcare applications, where the improved sensitivity can expand
the range of target analyte molecules to include those which are cur-
rently considered to be at impracticably low levels in situ, as well as to
improve the overall performance of the biodevice.
In the present paper we employ a nanoband array electrode, fabri-
cated using processes standard to the semiconductor industry with
very high reproducibility, to produce a high-sensitivity enzymatic glu-
cose sensor operating by immobilising the glucose oxidase (GOx) en-
zyme on the electrode surface. This utilizes the common first-
generation approach as employed in many commercial CGM devices
to illustrate the potential benefit a nanoband array could have in bio-
sensing [4]. The nanoband array electrode demonstrates a thousand-
fold improvement compared to a similarly designed macro electrode,
attributed to the particular properties of the nanoscale electrode
architecture.
2. Experimental
2.1. Materials
All chemicals used were of analytical grade and were purchased
from Sigma Aldrich, UK. Glucose oxidase from Aspergillus niger,
149.8 U mg−1, was used for the enzyme modification. All solutions
were prepared using deionised water with a measured ionic resistivity
of 18.2MΩ cm. An air-saturated 10mmol dm−3 phosphate buffered sa-
line (PBS), pH 7.4, containing 0.0027mol dm−3 potassium chloride and
0.137mol dm−3 sodium chloride was used throughout all experiments.
Glucose stock solutions (0.1 mol dm−3) were prepared with PBS and
were allowed to mutarotate overnight before use. A Pt Microsquare
Nanoband Edge Electrode (MNEE, Fig. 1 c) (CAVIARE™ Nanoband
Array, Platinum 303D, NanoFlex Limited, UK), discussed in more detail
in Section 3.1, or a 100 μm diameter Pt disc electrode were bio-
modified and used as working electrodes.
The fabrication processes used to obtain MNEE architectures are
standard to the semiconductor industry, employing thin film tech-
niques and lithography. As a result the device yields are extremely
high (N98%) with excellent reproducibility from device to deviceFig. 1. Diffusion field at a conventional and nanoband electrode. Illustration of the planar diffu
close proximity to a single nanoband within an aperture (b). (c) Schematic of the MNEE, not t
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ible for usewith flexible substrates using processing techniques that are
currentlywidely used for themass production of commercial disposable
electrochemical test strip devices at comparable manufacturing costs.
2.2. Electrode modification
Prior to use, theMNEE was cleaned electrochemically by cycling the
potential between −0.35 and 1.9 V (vs. SCE) at a scan rate of
100 mV s−1 for 10 cycles in 0.05 mol dm−3 H2SO4. The MNEE was
then incubated in conc. H2SO4 for 3 min followed by 50% H2SO4 for an-
other 3 min and thereafter rinsed copiously with water. To create the
glucose sensor, the Pt MNEE was first modified with 6-
Mercaptohexylamine thiol (MHA). Apart from gold, thiols are also
known to form well-defined monolayers on other metals, such as Pt
[21,22] Thiol modification was performed by incubating the MNEE for
20 h in 50 μmol dm−3 of MHA dissolved in ethanol. The electrode was
thereafter rinsed with ethanol followed by water. After thiol modifica-
tion, the electrode was incubated for 45 min in 20 μL 8% glutaraldehyde
solution (dissolved in water). Afterwards, the electrode was carefully
rinsed with buffer and 20 μL of 40 mg ml−1 GOx (dissolved in buffer)
was pipetted over the MNEE and left covered to prevent evaporation
for 2 h. The electrodes were finally rinsed with buffer and ready for
use. The Pt disc electrode was prepared in a similar.
2.3. Electrochemical measurements
All electrochemical experiments were carried out in a Faraday cage
using a DY2322 digital bipotentiostat (Digi-IVY, USA) The electrochem-
ical cell consisted of a three-electrode system using a PtMNEE or Pt disc
electrode as working electrode, platinum wire counter electrode and a
saturated calomel electrode (SCE) as reference. All electrochemical ex-
periments were carried out at room temperature. Prior to addition of
analyte, the working electrode was pre-conditioned by cycling the po-
tential 10 times between 0.2 and 0.9 V, where hydrogen peroxide will
be oxidised at the platinum surface. For glucose measurements, the
measurement solution was stirred at 600 rpm using a magnetic stirrer
bar to prevent build-up of hydrogen peroxide. Calibration curves of en-
zyme modified electrodes towards glucose were constructed from
chronoamperometry measurements at +0.7 V vs. SCE, averaging the
current at 60 s over 3 repeats, whilst stirring the solution.
3. Results and discussion
3.1. Glucose sensing at MNEE vs. disc electrode
We have previously demonstrated a Platinum (Pt) Microsquare
Nanoband Edge Electrode (MNEE) structure which was designed and
produced by utilising standard semiconductor processes andsion field of a conventional planar electrode (a) compared with the local diffusion field in
o scale.
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performance and relatively large currents, and which was shown to
have a high sensitivity for several common redox species [14,15]. The
MNEE consists of 30 × 30 μm edge length square apertures with a
120 μm pitch, producing 42 × 42 square elements. Within the recessed
walls of each aperture there is a 50 nm thick layer of exposed Pt, which
forms a nanoband electrode (Fig. 1c). TheMNEE formed has a total elec-
trode area of 0.0106 mm2 and provides a very stable and robust plat-
form for sensing. The architecture is described in more detail
elsewhere, where the mass transport-limited response is shown to be
reproducible, sensitive and steady-state (at short times, before diffusion
layer overlap from neighbouring array apertures occurs) [16,17]. In the
context of glucose sensing, the enhanced sensitivity obtainable with a
nanoband array electrode is of benefit, as this utilizes the enhanced
hemispherical diffusion to the electrode [16].
Specifically, the detection of glucose at a MNEE compared with a
macro-scale electrode is illustrated in Fig. 1. For planar devices the cur-
rent is time dependent and proportional to the square root of the sub-
strate diffusion coefficient, consistent with the expected linear
diffusion regime for glucose or oxygen, whereas for the MNEE it is di-
rectly proportional to the diffusion coefficient, consistentwith expected
nanoband edge electrode response [16]. Thus whilst physiological oxy-
gen concentrations are substantially lower than those of glucose, the
fourfold greater diffusion coefficient of the former and the diffusion re-
gime associated with the nanoband electrode significantly extend the
concentration range over which glucose can be measured before the
so-called oxygen deficit becomes apparent [18]. This reduces the
nanoelectrode sensitivity to limitations of oxygen concentration by re-
ducing mass transfer-based limitations and would be further enhanced
for implantable devices, where tissue formation around the implant
would impede the diffusion of glucose to a greater extent than that of
oxygen [19,20].
3.2. MNEE as a glucose sensor
To characterise the performance of the MNEE as a sensor, the
detection of hydrogen peroxide both on bare and enzyme-modified
electrodes was first investigated. Fig 2a shows typical cyclic
voltammograms of a bare MNEE to increasing amounts of hydrogen
peroxide in phosphate buffered saline (PBS) at a scan rate of
0.1 V s−1. A large catalytic response towards oxidation of hydrogen per-
oxide was observed, even at low concentrations, compared with the
very low background current in buffer (solid line in Fig. 2a, barely
visible).
The electrodes were investigated over awide concentration range of
hydrogen peroxide using cyclic voltammetry, and the current response
at +0.7 V vs. SCE, consistent with oxidation potentials commonly usedFig. 2. Response to H2O2 at a MNEE. (a) Cyclic voltammograms of a bare Pt MNEE in PBS, pH 7
(dotted line) and 2.2 mmol dm−3 (dash-dotted line) H2O2, recorded at a scan rate of 0.1 V s−
concentration of H2O2, taken from cyclic voltammograms at +0.7 V vs. Saturated Calomel Elec
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electrodes display a wide linear response and high sensitivity, with a
current response of 2.44 μA (mmol dm−3)−1 H2O2 (equal to 23 mA
(mmol dm−3)−1 cm−2), which was reduced by almost 30% when the
MNEE was modified with thiol and enzyme. A reduction in the current
of the bio-modified electrode is expected, as there is no glucose in the
solution to enable enzyme catalysed glucose oxidation and the thiol-
enzyme surface layer will inhibit transport of peroxide to the surface.
Due to the low current of the blank and high current from the peroxide
oxidation, very sensitive measurements are possible. This indicates that
the PtMNEEwould be very suitable as a highly sensitive first generation
type glucose biosensor.
To investigate the sensitivity of the MNEE towards glucose, sequen-
tial additions of glucose were performed. The results of an enzyme-
modifiedMNEE are shown in Fig 3. The CVs show a clear peaked shaped
response when glucose is added to the solution which in accordance
with Fig 2 is characteristic of hydrogen peroxide oxidation, produced
due to the catalytic oxidation of glucose. No response was observed
when no glucose was present (solid curve in Fig. 3a), when a bare
MNEE was used or when the solution was deoxygenated by bubbling
with nitrogen (data not shown). This shows that the enzyme is catalyt-
ically active on the surface in the presence of glucose.
In addition to cyclic voltammetry the electrodes were also investi-
gated using chronoamperometry in order to create a well-defined cali-
bration curve. Chronoamperometry was recorded for increasing
concentrations of glucose and the measurements were performed by
stepping the potential from +0.2 V to +0.7 V vs. SCE. The potential
was held for 60 s and three repeats were performed for each calibration
point, averaging the current at 60 s. The results of the calibration exper-
iments for enzyme-modified MNEE are shown in Fig. 3b (a typical
chronoamperometric response curve is shown in SI Fig.1). To ensure
no build-up of hydrogen peroxide at the electrode surface in the pres-
ence of glucose (as shown in SI Fig. 2), the solutionwas stirred. In an ac-
tual device, the build-up of hydrogen peroxide could be reduced by
immobilisation of an outer layer of catalase if it would be an issue,
whichwould actively oxidize excess hydrogen peroxide [3]. If operating
in the presence of very low glucose concentrations or operating contin-
uously, this is not likely to be an issue.
Based on the data displayed in Fig. 3b, theMNEE biosensor exhibited
a linear range between 0 and 10 mmol dm−3 glucose and a current
response of 27.9 nA (mmol dm−3)−1 glucose (equal to
263 μA (mmol dm−3)−1 cm−2). The current response is ca 60 times
lower for glucose compared to that observed for the same concentration
of added hydrogen peroxide (see Fig. 2). This is expected, as comparing
measurements of peroxide in bulk solution with peroxide measure-
ments resulting from localised turnover of glucose, we expect signifi-
cant differences in the concentrations at the electrode. In the bulk,.4, containing 0 mmol dm−3 (solid line), 0.1 mmol dm−3 (dashed line) 0.8 mmol dm−3
1. (b) Current of a bare (squares) and MHA-GOx-modified (circles) MNEE at increasing
trode (SCE).
a platform for high sensitivity enzyme-based glucose biosensing,
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Fig. 3. Response to glucose at a MNEE. (a) Cyclic voltammograms of a MHA-GOx-modified Pt MNEE in 10 mmol dm−3 PBS, pH 7.4, containing 0 mmol dm−3 (solid line), 5 mmol dm−3
(dotted line) and 10 mmol dm−3 (dash-dotted line) glucose, recorded at a scan rate of 0.1 V s−1. (b) Calibration curve of enzyme modified MNEE towards glucose, constructed from
chronoamperometry measurements at +0.7 V vs. SCE. Inset: Calibration curve over 0–10 mmol dm−3 glucose showing the linear fit to determine the sensitivity of the electrode from
the fitted slope.
4 M. Falk et al. / Bioelectrochemistry xxx (2016) xxx–xxxconcentrations of peroxide are broadly homogeneous and the electrode
response will be a function of the peroxide concentration which in turn
will determine the rate atwhich peroxidemolecules reach the electrode
surface. In the case of peroxide generated locally, as a consequence of
glucose turnover, a localised peroxide concentration developswhich re-
sults in rapid loss of peroxide to the bulk solution whose peroxide con-
centration tends towards zero. In the case of a stirred solution this
process is enhanced, ‘sweeping’ the peroxide from the locality of the
electrode. As a result, the limiting currents in the presence of glucose
are significantly lower than the case of bulk peroxide measurements.
However, despite the lower current response towards glucose com-
pared with hydrogen peroxide, very sensitive measurements were pos-
sible due to the very low background signal, with the average current of
the blank being roughly 0.3 nA (±24pA). A Limit OfDetection (LOD) for
the sensor was calculated as 2.6 μmol dm−3 glucose from the data given
in the calibration curve in Fig. 3b using the definition given by Commis-
sion Regulation (EC) No 333/2007: [21]
LOD ¼ 3 SDB
SCC
ð3Þ
where SDB is the standard deviation of the blank and SCC is the slope of
the linear fit obtained from the calibration curve.
For an oxidase-based sensor employing electrochemical oxidation of
hydrogen peroxide as a detectionmethod as describedherein, a number
of different compounds electroactive at the electrode potential used to
oxidize hydrogen peroxide can affect the sensor response, in particular
ascorbic acid. This is problematic for a sensor operating invasively (and
to a lesser extent for non-invasive sensing, depending on the biofluid
and presence of interferents), and a wide variety of approaches have
been developed to improve the selectivity, such as permselective mem-
braneswhichwork via size exclusion and/or electrostatic repulsion [22].
Similar approaches could be adopted for a MNEE. The simple approach
of drop-casting a Nafion membrane, a commonly used negatively
charged polymer, was shown to all but eliminate the response to ascor-
bic acid (SI Fig. 3). Naturally, this approach would need optimization
along with the enzyme deposition for an actual invasive device, with
an extensive investigation of the effect different possible interferents
as well as operation in the actual intended media, however this is be-
yond the scope of this paper.
3.3. Comparison with a Pt disc electrode as a glucose sensor
To illustrate the benefits the use of the MNEE brings, the perfor-
mance of the enzyme-modified MNEE was compared directly with a
conventional micro electrode having a similar overall electrode area.
Thus a 100 μm diameter Pt disc electrode (geometrical area ofPlease cite this article as: M. Falk, et al., Nanoband array electrode as
Bioelectrochemistry (2016), http://dx.doi.org/10.1016/j.bioelechem.2016.0.0079 mm2, vs. 0.0106 mm2 of exposed Pt for the MNEE), constructed
as described previously [15], wasmodifiedwith thiol and enzyme in the
same way as the MNEE (2.2, electrode modification). The Pt disc elec-
trodewas then characterised in the sameway as theMNEE, with the re-
sults shown in Fig. 4 (cf. Figs. 2a and 3b). The response towards
hydrogen peroxide is shown in Fig. 4a, exhibiting 2 orders of magnitude
lower current than theMNEE. Similar behaviour is observed for glucose,
where the lower current leads to a much lower sensitivity towards glu-
cose, as shown by the calibration curve in Fig. 4b, with a current re-
sponse of 41.9 pA (mmol dm−3)−1 glucose, roughly three orders of
magnitude lower than the MNEE (cf. Fig. 3b), whilst the blank currents
in buffer (no glucose present) are more than doubled for the Pt disc
electrode. Based on the calibration data, a LOD of 3.5 mmol dm−3 glu-
cose was obtained for the Pt disc electrode.
By employing a MNEE instead of a similar sized (electrode area) Pt
disc electrode, an improvement of three orders ofmagnitude in the sen-
sitivity was achieved. No difference in the stability of the enzymemod-
ifiedMNEE comparedwith the Pt disc electrodewas observed. Thewide
linear range and low LOD obtained when using the enzyme-modified
MNEE illustrates the large benefits achieved by employing a MNEE in
the biosensor design. The increased response of theMNEE can be attrib-
uted to the enhancedmass transport to a nanoband electrode combined
with the cumulative effect of an array of electrodes. This enables the
high diffusional rate and high signal-to-noise ratio of nanoelectrode
measurements to be combined with the high total current available
with arrays, although at extended times there is an increasing overlap
of the growing hemispherical diffusion layers of the individual
apertures.
GOx based electrochemical glucose sensors have been extensively
studied in the literature on a wide range of different support materials,
such as nanoparticles, nanofibres, nanotubes and nanocomposites. The
resulting material usually demonstrates high stability and reactivity,
primarily attributed to the high surface area of the catalysts. A direct
comparison of the performance between different approaches is often
not straight forward, due to the varying measurement conditions such
as rotation, oxygen concentration, use of a flow cell and measurement
protocol. Typical performance shown in some of the recently reported
papers display a similar linear sensing range as shown herein and a
LOD of 0.5–50 μmol dm−3, with typical sensitivities of 0.5–
80 μA (mmol dm−3)−1 cm−2 (cf. 263 μA (mmol dm−3)−1 cm−2 for
the MNEE above) [23–29].Indeed, the performance of the MNEE
(LOD b 3 μmol dm−3), produced using robust and reproducible silicon
semiconductor fabrication techniques, is comparable to nanoparticle-
or nanotube-modifiedmediated ormediatorless enzymatic glucose bio-
sensors. Instead of relying on a high surface area to achieve a high sen-
sitivity, the MNEE instead has a very low surface area but takes
advantage of the increased mass transport due to having a nanobanda platform for high sensitivity enzyme-based glucose biosensing,
04.002
Fig. 4. Response toH2O2 and glucose at a conventional electrode. (a) Cyclic voltammograms of aMHA-GOx-modified Pt disc electrode in PBS, pH 7.4, containing 0mmol dm−3 (solid line),
0.1 mmol dm−3 (dotted line) and 1mmol dm−3 (dash-dotted line) H2O2, recorded at a scan rate of 0.1 V s−1. (b) Calibration curve of enzymemodified Pt disc electrode towards glucose,
constructed from chronoamperometry measurements at +0.7 V vs. SCE. Inset: Calibration curve over 0–10mmol dm−3 glucose showing the linear fit to determine the sensitivity of the
electrode from the fitted slope.
5M. Falk et al. / Bioelectrochemistry xxx (2016) xxx–xxxto achieve the same. The use of a MNEE thus provides a nanoparticle
free alternative to more commonly nano-modified macro-scaled glu-
cose biosensors, usingmaterialswell established in commercial devices.
The benefits shown here for a glucose biosensor would also be ex-
pected to be shown for MNEEs employed in the design of other biosen-
sor systems. In the context of CGM, device accuracy, limited linear range
and limited lifetime are ongoing challenges. Based on the data pre-
sented herein, the use of a MNEE would be expected to provide signifi-
cant benefits. The efficient mass transfer and consequently wide linear
range would be expected to reduce the need for membranes currently
required to favour oxygen over glucose diffusion to the electrode sur-
face [8]. The higher sensitivity exhibited by the MNEE provides the po-
tential to reduce electrode size or increase the number of individually
addressable sensors allowing for sensor redundancywith associated po-
tential improvements in accuracy, reliability and lifetime. The high sen-
sitivity of the sensor would also be of great importance if applied for
non-invasive sensing, where the glucose is present at much lower con-
centrations compared to those in blood.4. Conclusions
The results reported here suggest that a significant benefit can be ob-
tained in a common glucose sensor design by using a nanoband array
electrode instead of a conventional electrode, with an improvement of
three orders of magnitude achieved in the herein investigated system.
This illustrates an important potential application of MNEEs in
bioanalytical measurement systems, providing a robust and manufac-
turable sensing platform and where the improved sensitivity could ex-
pand the range of target analyte molecules to include those which are
currently considered to be at impracticably low levels or inaccessible
due to mass transport issues.Acknowledgements
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